Presentation is loading. Please wait.

Presentation is loading. Please wait.

Reward - Drug Abuse Anatomy Physiology Pathophysiology

Published byJanice Norton Modified over 5 years ago

Similar presentations

Presentation on theme: "Reward - Drug Abuse Anatomy Physiology Pathophysiology"— Presentation transcript:

1 Reward - Drug Abuse Anatomy Physiology Pathophysiology

2 Rational Approach to CNS Pharmacotherapy
Behaviors - Symptoms  Circuits  Neurotransmitter Systems  Neuropharmacological TARGETS SGO tf

3 Pharmacologic Principles Underlying Drug Abuse
Acute Intoxication [OPI - GABA - NMDA - DA NE - 5HT - ACh - CB] Reinforcing Properties Euphoria [DA / 5HT / OPI /CB] Anxiolysis [GABA] CNS Stimulation [DA / NE / ACh] Altered Perception [5HT] Pharmacodynamics Pharmacokinetics ER Chronic Use Prescribing Controlled Substances Medical Medical / Social Consequences Relapse Craving [DA / NMDA] Tolerance / Dependence Pharmacodynamic & Pharmacokinetic Psychiatry ER Abstinence Withdrawal Rebound Hypersensitivity

4 1. Brain pathway central to the reinforcing actions of dopaminergic drugs.
Substantia nigra  striatum Striatum  globus pallidus Ventral tegmental area  nucleus accumbens Ventral tegmental area  prefrontal cortex Locus ceruleus  prefrontal cortex

5 for survival and reproduction
Brain Reward Pathways Hypothalamus as “Master Effector” for survival and reproduction

6 1. Brain pathway central to the reinforcing actions of dopaminergic drugs.
Substantia nigra  striatum Striatum  globus pallidus Ventral tegmental area  nucleus accumbens Ventral tegmental area  prefrontal cortex Locus ceruleus  prefrontal cortex

7 Physiologic Role of Reward Pathway
Normal function: Mediate pleasure perception (reward) and strengthen behaviors (reinforcement) associated with natural reinforcers Produces motivational states that modulate physiological-behavioral responses ensuring survival and reproduction Complementary pathway to networks for learning about dangerous stimuli (fear)

8 Amygdala  Fear-Related Information Flow

9 Physiologic Role of Reward Pathway
Reward: Stimulus interpreted as intrinsically positive – something to be approached Drug-induced pleasurable states are strong motivators of initial drug use Reinforcing stimulus: Increases probability that behaviors paired with it will be repeated

10 Brain Reward Pathways Ventral Tegmental Area [VTA]  Nucleus Accumbens [NA] Major components of reward and reinforcement circuitry Function as interface between limbic emotional-motivational information and extrapyramidal regulation of motor behavior

11 Brain Reward Pathways Hippocampus Amygdala
Memory circuit that mediates associations between biologic stimuli (or drugs) and environmental cues Amygdala Integrative structure that is critical to formation of stimulus-reward associations

12 Brain Reward Pathways Prefrontal Cortex
Critical for executive function in providing control over impulses from destructive behavior - impairment important mediator of loss of control

13 Rational Approach to CNS Pharmacotherapy
Behaviors - Symptoms  Circuits  Neurotransmitter Systems  Neuropharmacological TARGETS

14 2. Neurotransmitter central to pathologic learning in reward pathway.
Acetylcholine Dopamine Endocannabinoids Enkephalins GABA Glutamate Serotonin

15 Common Pathway - Reward-Reinforcement NTs
Natural reinforcers produce sensory cues that activate reward pathway VTA activation releases DA onto NA neurons  pleasure perceived and identifies stimulating activity as one to be repeated Drugs of abuse - acting via multiple NT systems - share final common pathway and also increase DA release in the nucleus accumbens The more intense and more direct this effect on DA release  greater the addiction potential of the drug Dopamine Terminal Natural Reinforcers Dopamine Neuron

16 Reactive Reward System - VTA  NA
[1] Amygdala to VTA functions to signal prospect of pleasure-reward (relevance detection) from natural reinforcers and provides motivational state to achieve it [2] Drug-induced DA release (VTA to NA) is more explosive (pleasurable) than with natural reinforcers The more intense and more direct this effect on DA release  greater the addiction potential of the drug Natural Reinforcers Drugs of Abuse [2] [1] [1] Drugs of Abuse

17 Reactive Reward System - VTA  NA
[3] Repeated drug exposures result in pathologic learning (VTA to amygdala) to trigger drug-seeking behavior when presented with drug cues [4] Amygdala to NA and VTA signals triggering of emotional memories by drug cues that then initiates behavior to seek and take drugs Drug Addiction thus “hijacks” the normal reward circuitry Natural Reinforcers [4] Drugs of Abuse [2] [1] [1] [3] [4] Drugs of Abuse

18 2. Neurotransmitter central to pathologic learning in reward pathway.
Acetylcholine Dopamine Endocannabinoids Enkephalins GABA Glutamate Serotonin

19 Reflective Reward System - PFC  NA
Prefrontal cortex to nucleus accumbens Orbitofrontal  regulating impulses Dorsolateral  analysis of situation Ventromedial  integration with emotions Complementary and competitive component of reactive reward system System built over time with influences from: Genetics Neurodevelopment Experience Peer pressure Learning social rules

20 Balance between reflective and reactive systems determines output of reward circuitry Natural rewards vs Drug-seeking

21 Compulsive Drug Use - Addiction
Reflective Reward Reactive Reward [1,2] Amygdala learns drug and cues cause pleasure – may signal relief from craving [3] Drug cues lead to DA release in NA  triggers output to thalamus and cortex [4] [4] In absence of activity from reflective reward system  drug-seeking initiated

22 Drug Addiction Progressive behavioral syndrome  compulsive drug-seeking and drug-taking despite serious consequences Loss of ability to make choices promoting happiness and survival Weakening of executive function  PFC-NA pathways Realization of destructive nature of addiction - unable to alter behavior Strengthening of working memory-habit  striatal-cortical pathways Pathologic effects of drugs mediated in large part via actions – acute and chronic – on the brain Reward Pathway

23 Proposed Sites of Drug Action in Alcohol Reinforcement Pathways
Neurotransmitter Systems

24 Reward - Drug Abuse Pharmacology

25 Pharmacologic Principles Underlying Drug Abuse
Acute Intoxication [OPI - GABA - NMDA - DA NE - 5HT - ACh - CB] Reinforcing Properties Euphoria [DA / 5HT / OPI /CB] Anxiolysis [GABA] CNS Stimulation [DA / NE / ACh] Altered Perception [5HT] Pharmacodynamics Pharmacokinetics ER Chronic Use Prescribing Controlled Substances Medical Medical / Social Consequences Relapse Craving [DA / NMDA] Tolerance / Dependence Pharmacodynamic & Pharmacokinetic Psychiatry ER Abstinence Withdrawal Rebound Hypersensitivity

26 Variables Influencing Drug Abuse Pharmacodynamics
Reinforcing Properties Drugs that reliably produce intense feelings of pleasure are more likely to be abused All drugs with abuse liability share property of enhancing dopamine activity in nucleus accumbens

27 Common Pathway - Reward and Reinforcement
Natural reinforcers produce sensory cues that activate reward pathway VTA activation releases DA onto NA neurons  pleasure perceived and identifies stimulating activity as one to be repeated Drugs of abuse - acting via multiple NT systems - share final common pathway and also increase DA release in the nucleus accumbens The more intense and more direct this effect on DA release  greater the addiction potential of the drug Dopamine Terminal Natural Reinforcers Dopamine Neuron

28 3. Which mechanism of drug action is associated with the greatest risk for development of addictive behaviors? Increased release of norepinephrine Increased release of dopamine Activation of mu-opioid receptors Block of NDMA-glutamate receptors Activation of CB-1 receptors Block of dopamine transporter (DAT) Partial agonist at 5-HT2A receptors Block of D2 receptors

29 Variables: Pharmacodynamics of Drug Abuse
[4] [4] [3] [3] [4] [3] [5] [1] Benzodiazepines [4] [2] Relative Risk of Addiction: 1 = nonaddictive, 5 = highly addictive

30 Initial Pharmacodynamic Actions - Addictive Drugs Relative Risk
Drug Molecular Target Mode of Action Effect on DA Neurons of Addiction Stimulants Cocaine DAT (+ SERT-NET) Inhibitor Blocks DA Uptake Methamphetamine DAT (+ SERT-NET, VMAT) Reverses transporter DA releaser Nicotine Nicotinic receptor Agonist Excitation MDMA (Ecstasy) SERT > DAT, NET Reverses transporter (5HT releaser) ? Opioids  opioid receptor [Gi/o] Agonist Disinhibition CNS Depressants Alcohol GABA-A channel Complex-facilitate Excitation, disinhibition NMDA receptor Complex-antagonize Benzodiazepines GABA-A channel Positive modulator Disinhibition Cannabinoids CB1 receptor [Gi/o] Agonist Disinhibition Marijuana Hallucinogens 5-HT2A receptor [Gq] Partial agonist (- - -) LSD, psilocybin, MDMA Dissociative Anesthetics NMDA receptor Antagonist (- - -) Phencyclidine, Ketamine ___________________________________________________________________________________________________

31 3. Which mechanism of drug action is associated with the greatest risk for development of addictive behaviors? Increased release of norepinephrine Increased release of dopamine Activation of mu-opioid receptors Block of NDMA-glutamate receptors Activation of CB-1 receptors Block of dopamine transporter (DAT) Partial agonist at 5-HT2A receptors Block of D2 receptors

32 4. A drug of abuse that blocks the reuptake of dopamine and norepinephrine into presynaptic catecholamine neurons and also blocks sodium channels in neuronal membranes is: Methamphetamine Nicotine MDMA Lysergic acid diethylamide (LSD) Cocaine Mescaline

33 4. A drug of abuse that blocks the reuptake of dopamine and norepinephrine into presynaptic catecholamine neurons and also blocks sodium channels in neuronal membranes is: Methamphetamine Nicotine MDMA Lysergic acid diethylamide (LSD) Cocaine Mescaline

34 Dopamine, Pharmacokinetics, and Reinforcing Effects
Reinforcing Effects of Drugs Rate at which DA increases in brain Abrupt and large increase in striatal DA mimics phasic DA firing associate with reward and saliency

35 Variables Influencing Drug Abuse Pharmacokinetics
Rate of Onset of Action Abuse liability increased with faster of onset of action Route of Administration – correlated with onset of effect Inhalation – highly addictive Onset of effects within 7 sec User can titrate blood levels precisely Preferred by users of cocaine, nicotine, methamphetamine, cannabis

36 Variables Influencing Drug Abuse Pharmacokinetics
Route of Administration – correlated with onset of effect Intravenous – highly addictive Onset of effects within sec (IM-SC within 3-5 min) Large amount of drug enters blood rapidly  most intense rush-like feelings Most dangerous route  exaggerated reactions, infections, overdose toxicities

37 Variables Influencing Drug Abuse Pharmacokinetics
Route of administration – correlated with onset of effect Mucous membrane absorption Most commonly via insufflation – effects within 3-5 minutes More rapid and intense than oral (bypasses liver) Oral Easiest route of administration – onset of effects delayed minutes Difficult to obtain rush feelings via this route BUT will prevent withdrawal symptoms – useful route in treatment programs

38 Rate of Onset of Action Nicotine Cp Resulting from 5 Different Delivery Systems

39 5. Which route of administration for psychoactive drugs will provide the most rapid onset of effects in the brain? Insufflation (nasal) Inhalation (smoking) Subcutaneous Oral Suppository Intramuscular Intravenous

40 5. Which route of administration for psychoactive drugs will provide the most rapid onset of effects in the brain? Insufflation (nasal) Inhalation (smoking) Subcutaneous Oral Suppository Intramuscular Intravenous

41 Variables: Pharmacokinetics of Drug Abuse
Termination of Effects Within a class of abused drugs  drugs with shorter half-lives have higher abuse potential Acute considerations Quick offset  frequent administrations  increased likelihood for loss of control Inhalation of cocaine (free base) more addicting than insufflation (flakes)

42 Termination of Effects Differences in Responses to Heroin and Methadone
t1/2 = 30 min t1/2 = 8-59 h

43 Variables: Pharmacokinetics of Drug Abuse
Termination of Effects Chronic considerations Withdrawal effects more severe for drugs with short half-lives Leads to continued drug administration simply to prevent withdrawal Heroin (short t1/2) more addicting than methadone (long t1/2)

44 Termination of Effects For a drug-dependent individual, the more rapidly the target-receptor becomes unoccupied by drug, the more severe the withdrawal effects

45 Pharmacologic Principles Underlying Drug Abuse
French Acute Intoxication [OPI - GABA - NMDA - DA NE - 5HT - ACh - CB] Reinforcing Properties Euphoria [DA / 5HT / OPI /CB] Anxiolysis [GABA] CNS Stimulation [DA / NE / ACh] Altered Perception [5HT] Pharmacodynamics Pharmacokinetics ER Chronic Use Sakai Prescribing Controlled Substances Medical Medical / Social Consequences Relapse Craving [DA / NMDA] Tolerance / Dependence Pharmacodynamic & Pharmacokinetic Psychiatry ER Abstinence Friday Withdrawal Rebound Hypersensitivity

Download ppt "Reward - Drug Abuse Anatomy Physiology Pathophysiology"

Similar presentations

OPTION E E4 NEUROTRANSMITTERS AND SYNAPSES

OPTION E E4 NEUROTRANSMITTERS AND SYNAPSES
OPTION E E4 NEUROTRANSMITTERS AND SYNAPSES

OPTION E E4 NEUROTRANSMITTERS AND SYNAPSES
E.4 Neurotransmitters and Synapses. E4.1 Postsynaptic Responses Pre-synaptic neurons can inhibit or excite the post synaptic neuron by releasing excitatory.

E.4 Neurotransmitters and Synapses. E4.1 Postsynaptic Responses Pre-synaptic neurons can inhibit or excite the post synaptic neuron by releasing excitatory.
Drugs of Addiction and Alcohol Effects on the Brain By Jonathan Godon & Eric Albuquerque Science 8-4.

Drugs of Addiction and Alcohol Effects on the Brain By Jonathan Godon & Eric Albuquerque Science 8-4.
Neurotransmitters Many Neurotransmitters (NT) exist: -Dopamine -Adrenaline -Serotonin -Acetylcholine Drugs can either: –Increase the effect of certain.

Neurotransmitters Many Neurotransmitters (NT) exist: -Dopamine -Adrenaline -Serotonin -Acetylcholine Drugs can either: –Increase the effect of certain.
Psychoactive Drugs Drugs that affect the brain, changing mood or behavior. 80-90% of adults in North America use some kind of drug on a daily basis. The.

Psychoactive Drugs Drugs that affect the brain, changing mood or behavior % of adults in North America use some kind of drug on a daily basis. The.
Topics for this lecture Drugs - All drugs of abuse induce dopamine release (?) The anatomy of the reward pathway defines the road to drug abuse (?) Cellular.

Topics for this lecture Drugs - All drugs of abuse induce dopamine release (?) The anatomy of the reward pathway defines the road to drug abuse (?) Cellular.
The Neurobiology of Addiction

The Neurobiology of Addiction
Drugs, Addiction and Reward. Stimulants Behavioral Effect: increase activity, arousal, excitement, etc. Primary Mechanism of Action: Activation of D2-D4.

Drugs, Addiction and Reward. Stimulants Behavioral Effect: increase activity, arousal, excitement, etc. Primary Mechanism of Action: Activation of D2-D4.
 Remember, your brain grows until what age ____???  Also, the amygdala is _______________which makes your brain more sensitive to new, exciting, dangerous.

 Remember, your brain grows until what age ____???  Also, the amygdala is _______________which makes your brain more sensitive to new, exciting, dangerous.
1 Common Features of Addiction Physical versus Psychological Addiction Tolerance: The fact that increasingly large doses of drugs must be taken to achieve.

1 Common Features of Addiction Physical versus Psychological Addiction Tolerance: The fact that increasingly large doses of drugs must be taken to achieve.
Neurobiology of drug action and addiction Richard Palmiter Dept Biochemistry.

Neurobiology of drug action and addiction Richard Palmiter Dept Biochemistry.
Neurotransmitters, Mood and Behaviour

Neurotransmitters, Mood and Behaviour
Drug Tolerance Cross Tolerance Metabolic Tolerance

Drug Tolerance Cross Tolerance Metabolic Tolerance
Biology of Substance Abuse

Biology of Substance Abuse
. © 2009 McGraw-Hill Higher Education. All rights reserved. 1 Chapter Twelve Drugs: Use, Abuse, and Control.

. © 2009 McGraw-Hill Higher Education. All rights reserved. 1 Chapter Twelve Drugs: Use, Abuse, and Control.
Terrence D. Walton, MSW, CSAC Pretrial Services Agency for the

Terrence D. Walton, MSW, CSAC Pretrial Services Agency for the
Chapter Four Psychopharmacology Version Dated 21 Sep 2009.

Chapter Four Psychopharmacology Version Dated 21 Sep 2009.
Drugs of Abuse: Clinical Signs and symptoms

Drugs of Abuse: Clinical Signs and symptoms
 Remember, your brain grows until what age ____???  Also, the amygdala is _______________which makes your brain more sensitive to new, exciting, dangerous.

 Remember, your brain grows until what age ____???  Also, the amygdala is _______________which makes your brain more sensitive to new, exciting, dangerous.

Similar presentations

Ads by Google